BRAIN Biotech AG
XETRA:BNN

Watchlist Manager
BRAIN Biotech AG Logo
BRAIN Biotech AG
XETRA:BNN
Watchlist
Price: 3.44 EUR -0.86% Market Closed
Market Cap: 75.2m EUR
Have any thoughts about
BRAIN Biotech AG?
Write Note

BRAIN Biotech AG
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

BRAIN Biotech AG
Operating Expenses Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
BRAIN Biotech AG
XETRA:BNN
Operating Expenses
-€37.7m
CAGR 3-Years
-7%
CAGR 5-Years
3%
CAGR 10-Years
N/A
Wacker Chemie AG
XETRA:WCH
Operating Expenses
-€876.6m
CAGR 3-Years
-11%
CAGR 5-Years
-7%
CAGR 10-Years
-6%
Evonik Industries AG
XETRA:EVK
Operating Expenses
-€3.8B
CAGR 3-Years
-11%
CAGR 5-Years
2%
CAGR 10-Years
-5%
Covestro AG
XETRA:1COV
Operating Expenses
-€2.1B
CAGR 3-Years
-1%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
AlzChem Group AG
XETRA:ACT
Operating Expenses
-€251m
CAGR 3-Years
-6%
CAGR 5-Years
-22%
CAGR 10-Years
N/A
Symrise AG
XETRA:SY1
Operating Expenses
-€1.2B
CAGR 3-Years
-9%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
No Stocks Found

BRAIN Biotech AG
Glance View

Market Cap
75.2m EUR
Industry
Chemicals

BRAIN Biotech AG is a technology company, which engages in the development and commercialization of bioactives, natural compounds, and proprietary enzymes. The company is headquartered in Zwingenberg, Hessen and currently employs 293 full-time employees. The company went IPO on 2016-02-09. Research & Development activities focus on bioactive natural compounds, tailored enzymes and high-performance microorganisms.

BNN Intrinsic Value
5.17 EUR
Undervaluation 33%
Intrinsic Value
Price

See Also

What is BRAIN Biotech AG's Operating Expenses?
Operating Expenses
-37.7m EUR

Based on the financial report for Jun 30, 2024, BRAIN Biotech AG's Operating Expenses amounts to -37.7m EUR.

What is BRAIN Biotech AG's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
3%

Over the last year, the Operating Expenses growth was -5%. The average annual Operating Expenses growth rates for BRAIN Biotech AG have been -7% over the past three years , 3% over the past five years .

Back to Top